Cargando…

Ethical considerations of publication planning in the pharmaceutical industry

Detalles Bibliográficos
Autores principales:	Fugh-Berman, Adriane, Dodgson, Susanna J
Formato:	Texto
Lenguaje:	English
Publicado:	Open Medicine Publications, Inc. 2008
Materias:	Analysis and Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091612/ https://www.ncbi.nlm.nih.gov/pubmed/21602956

Ejemplares similares

How Basic Scientists Help the Pharmaceutical Industry Market Drugs
por: Fugh-Berman, Adriane
Publicado: (2013)

Pharmaceutical marketing: the example of drug samples
por: Alagha, Emily Couvillon, et al.
Publicado: (2022)

Prescription Tracking and Public Health
por: Fugh-Berman, Adriane
Publicado: (2008)

Toward a definition of pharmaceutical innovation
por: Morgan, Steven, et al.
Publicado: (2008)

Ethical considerations in international clinical trial site selection
por: Miller, Jennifer, et al.
Publicado: (2022)

Ethical considerations for researchers developing and testing minimal-risk devices
por: Wexler, Anna, et al.
Publicado: (2023)

Evaluation of pharmaceutical industry-led access programmes: a standardised framework
por: Rockers, Peter C, et al.
Publicado: (2019)

Justice: a key consideration in health policy and systems research ethics
por: Pratt, Bridget, et al.
Publicado: (2020)

The ethics of organ donation after cardiocirculatory death: Do the guidelines of the Canadian Council for Donation and Transplantation measure up?
por: Browne, Alister
Publicado: (2010)

Public health and ethical considerations in planning for quarantine.
por: Cetron, Martin, et al.
Publicado: (2005)

The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
por: Fugh-Berman, Adriane J.
Publicado: (2010)

Academic Alternate Relationship Plans for internal medicine: a lever for health care transformation
por: Bichel, Allison, et al.
Publicado: (2011)

Endovascular treatment for multiple sclerosis: The intersection of science, policy and the public
por: Laupacis, Andreas, et al.
Publicado: (2010)

Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia
por: Wood, Susan F., et al.
Publicado: (2017)

Off-Label Promotion, On-Target Sales
por: Fugh-Berman, Adriane, et al.
Publicado: (2008)

Following the Script: How Drug Reps Make Friends and Influence Doctors
por: Fugh-Berman, Adriane, et al.
Publicado: (2007)

Bioidentical Hormones for Menopausal Hormone Therapy: Variation on a Theme
por: Fugh-Berman, Adriane, et al.
Publicado: (2007)

Do New Drugs Increase Life Expectancy? A Critique of a Manhattan Institute Paper
por: Baker, Dean, et al.
Publicado: (2009)

Public reporting of the hospital standardized mortality ratio (HSMR): implications for the Canadian approach to safety and quality in health care
por: Brien, Susan E, et al.
Publicado: (2008)

A vision for cannabis regulation: a public health approach based on lessons learned from the regulation of alcohol and tobacco
por: Haden, Mark, et al.
Publicado: (2014)

Monitoring non-pharmaceutical public health interventions during the COVID-19 pandemic
por: Shen, Yannan, et al.
Publicado: (2021)

Genomics in the era of COVID-19: ethical implications for clinical practice and public health
por: Geller, Gail, et al.
Publicado: (2020)

Public health use of HIV phylogenetic data in sub-Saharan Africa: ethical issues
por: Jamrozik, Euzebiusz, et al.
Publicado: (2023)

Correction: Advertising in Medical Journals: Should Current Practices Change?
por: Fugh-Berman, Adriane, et al.
Publicado: (2006)

Advertising in Medical Journals: Should Current Practices Change?
por: Fugh-Berman, Adriane, et al.
Publicado: (2006)

Pharmaceutical security for Canada
por: Lee, Shoo K., et al.
Publicado: (2022)

Ethical considerations for mystery shopper studies of pharmaceutical sales
por: Collins, Jack C, et al.
Publicado: (2020)

Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era
por: Juengst, Eric T., et al.
Publicado: (2020)

Salespeople in the Surgical Suite: Relationships between Surgeons and Medical Device Representatives
por: O’Connor, Bonnie, et al.
Publicado: (2016)

Direct-to-consumer Marketing to People with Hemophilia
por: Kucab, Philip, et al.
Publicado: (2016)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Ethical guidance or epistemological injustice? The quality and usefulness of ethical guidance for humanitarian workers and agencies
por: Sheather, Julian, et al.
Publicado: (2022)

SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
por: Boehme, Catharina, et al.
Publicado: (2021)

Making pharmaceutical research and regulation work for women
por: Ravindran, TK Sundari, et al.
Publicado: (2020)

Frank words about breast screening
por: Baines, Cornelia J
Publicado: (2011)

Reporting test results directly to patients: Is there anything to lose?
por: Kendall, Claire, et al.
Publicado: (2011)

The use of quality indicators to promote accountability in health care: the good, the bad, and the ugly
por: Forster, Alan J, et al.
Publicado: (2012)

Better access to outpatient magnetic resonance imaging in Ontario – But for whom?
por: You, John J, et al.
Publicado: (2009)

The effectiveness and safety of emergency department short stay units: a rapid review
por: Konnyu, Kristin J, et al.
Publicado: (2012)

CNODES: the Canadian Network for Observational Drug Effect Studies
por: Suissa, Samy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_doj3jhb1qfg1t1ln5r5l4lpstu